companydata.dkShire Biotech Denmark ApS: Financial statements 2014
CVR: 33358008
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 7,151,469 and a net result of DKK 342,653 compared with DKK 231,818 the year before. That is an increase of 50.5% compared with the year before. Equity amounted to DKK 903,240. The solvency ratio was 23.6%.
- Gross Profit
- 7,151,469 kr.
- Profit/Loss
- 342,653 kr.
- Equity
- 903,240 kr.
- Total Assets
- 3,823,407 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 7.2 mio. | 343 t. | 903 t. | - |
| 2013 | - | 4.8 mio. | 232 t. | 561 t. | - |
| 2012 | 4.1 mio. | 4.1 mio. | 93 t. | 329 t. | - |
Keep an eye on Shire Biotech Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
Shire Biotech Denmark ApS has published its annual report for 2013. Gross profit came to DKK 4,752,701, and the net result was DKK 231,818.
As of April 8, 2014, Helen Rosemary Janaway has joined the board of directors of Shire Biotech Denmark ApS.
As of April 8, 2014, Michael Thomas Garry has left the board of directors of Shire Biotech Denmark ApS.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010 and dissolved in 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees. In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity amounted to DKK 3,207,794.